©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2007; 13(48): 6608-6611
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6608
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6608
Table 2 Summary of previously reported cases of serious (fatal and non-fatal) drug-induced liver damage following treatment with imatinib mesylate
| Reference | Diagnosis | Time tohepaticdysfunction | Liverhistology | Outcome ofliver enzymes |
| Ohyashiki et al (2002) | CML | 12 d | Focal necrosis of hepatocytes | Resolution after stopping drug |
| Lin et al (2003) | Polycythemia vera | 7 wk | Hepatic necrosis | Patient died fatal acute hepatic necrosis |
| James et al (2003) | CML | 49 wk | Acute severe cytolytic hepatitis. | Resolution after stopping drug |
| With necrosis and mild cholestasis | ||||
| CML | 22 wk | Acute cytolytic hepatitis with spotty and some piecemeal necrosis | Resolution after stopping drug | |
| Kikuchi et al (2004) | CML | 36 wk | Hepatic necrosis | Resolution after stopping drug |
| Ayoub et al (2005) | CML | 2 yr | Portal and lobular inflammation. | Resolution after stopping drug |
| Bridging and multifocal lobular necrosis | ||||
| Cross et al (2007) | CML | 77 wk | Severe necrosis with multilobular confluent cell dropout and reticulin collapse, multinodular regeneration | Patient died 10 d after liver transplantation |
| Ridruejo et al (2007) | CML | 22 wk | Not available | Patient died fatal acute hepatic necrosis |
- Citation: Ridruejo E, Cacchione R, Villamil AG, Marciano S, Gadano AC, Mandó OG. Imatinib-induced fatal acute liver failure. World J Gastroenterol 2007; 13(48): 6608-6611
- URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6608.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i48.6608